[Initial experience with autologous thrombocytes labeled with 111indium-oxine]. 1989

A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta

The authors elaborated their own modification of the separation and labelling of autologous thrombocytes by means of 111indium-oxine which can be implemented in Czechoslovak departments of nuclear medicine with standard equipment. A total of 123 separations and labellings were made and 85 administrations to patients. The effectiveness of labelling by the described method was 79.5 +/- 6.9%, the separation yield of thrombocytes with regard to complete blood 44.3 +/- 13.8%. The aggregating capacity of the labelled platelets assessed in vitro after ADP stimulation (adenosine diphosphate) was 39.5 +/- 10.1% difference in optic density of platelet rich and platelet poor plasma which is evidence of the preserved viability of thrombocytes. "Recovery" during the 120th minute after administration of normal suspensions was 62.2 +/- 17.9%, the survival time of labelled thrombocytes 8.2 +/- 0.74 days. In patients with idiopathic thrombocytopenic purpura the "recovery" was 49.4 +/- 18%, the survival period 2.9 +/- 1.8 days. In patients after transplantation of the kidney complicated by acute rejection there was an increased accumulation of labelled platelets in the area of the kidney (count rate index 2.32 +/- 0.45). In normally functioning transplanted kidneys the count rate index was 1.42 +/- 0.06. On their own material the authors demonstrate other possibilities of clinical application of scintigraphy by means of labelled autologous platelets (a method hitherto not described in the Ccezhoslovak literature) for the detection of intracardial and arterial thrombosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006912 Hydroxyquinolines The 8-hydroxy derivatives inhibit various enzymes and their halogenated derivatives, though neurotoxic, are used as topical anti-infective agents, among other uses. Quinolinols,Chiniofon
D015125 Oxyquinoline An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics. 8-Quinolinol,Oxine,Oxyquinol,8-Hydroxyquinoline,8-Hydroxyquinoline Sulfate,8-Oxyquinoline,Bioquin,Chinosol,Khinozol,Leioderm,Oxyquinoline Potassium Sulfate (2:1),Oxyquinoline Sulfate,Quinosol,Superol,8 Hydroxyquinoline,8 Hydroxyquinoline Sulfate,8 Oxyquinoline,8 Quinolinol,Sulfate, 8-Hydroxyquinoline,Sulfate, Oxyquinoline

Related Publications

A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
January 1983, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
January 1980, Radiologia diagnostica,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
January 1985, Clinical nuclear medicine,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
September 1984, Cancer,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
January 1985, European journal of nuclear medicine,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
January 1983, European journal of nuclear medicine,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
January 1984, Duodecim; laaketieteellinen aikakauskirja,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
August 1979, Scandinavian journal of haematology,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
December 1987, Biology of reproduction,
A Fikrle, and I Knedlhansová, and M Suchý, and V Cepelák, and D Slípková, and J Klecka, and J Valenta
January 1982, Acta medica Austriaca,
Copied contents to your clipboard!